1.

Bibliography

1. Herman T.W., (1995), Recent research on bioavailability of drugs from

suppositories. Int J Pharm. 123, 1-11.
2. Howard R. & Fix J.A., (2002), In: James Swarbrick & Boylan JC (eds)
Encyclopedia of pharmaceutical technology. 2 nd edition, Marcel Dekker Inc., New York.
Vol. 1, 932-43.
3. Asakura S., Ueda H., & Ohnisihi N. Dissolution profiles of ceftizoxime
suppository. Drug Develop Ind Pharm. 19(13), 1629-36.
4. Webster J.A., Dowse R. & Walker R.B. (1998), In vitro release of amoxycillin
from lipophilic suppositories. Drug Develop Ind Pharm. 24 (40), 395-99.
5. Novak E., Osborne D.W., Matheson L.E., Parrot E.L., Lach S.L. & Morrison W.B.
(1991), Evaluation of cefmetazole rectal suppository formulation(s). Drug Develop Ind
Pharm. 17(3), 973-89.
6. Kim Y.A. & Young K.S. (2000), Enhanced absorption of indomethacin after oral
or rectal administration of self-emulsifying system containing indomethacin to rats. Int J
Pharm. 194, 81-89.
7. Basvaraj B.V. & Nanjudaswamy N.G. (2005), Formulation & evaluation of
paracetamol suppositories adapting various bases & adjuvants. Indian Drugs. 42(5),
305-8.
8. Martinez M.T., Herrero R., Gutierrez J.A., Iglesias J.M. & Fabregass J.C.
(1993), Bioavailability & bioequivalence of two formulations of etodolac (tablets &
suppositories). J Pharm Sci. 82(2), 211-213.
9. Babar A., Bellete T. & Plagkogiannis F.M. (1999), Ketoprofen suppository dosage
forms: In vitro release & in vivo absorption studies in rabbits. Drug Develop Ind Pharm.
25(2), 241-245.
10. Ahmed M.N. & B&hopadhyay A.K. (2001), Development & evaluation of
micropelleted sustained release suppositories of theophylline. Indian Drugs. 38(3), 150-
152.
11. Maity S. & B&hopadhyay K. (2001), Development of sustained release
suppositories of terbutaline sulphate. Indian J Pharm Sci. 256-258.
12. Laura C., Nix S., Ermer J., Decleence S., Cevallos W. & Mayer P.R. (2000),
Pharmacokinetics of promathazine hydrochloride after administration of rectal
suppositories & oral syrup to healthy subjects. American J Health System
Pharm.57(16), 1499-1505.
13. Arunya U. & Bragadeesh R.I. (1999), effect of 2-hydroxyl propyl--cyclodextrin on
in vitro drug release of steroids from suppository bases. Drug Develop Ind Pharm.
25(3), 387-90.
14. Pienaar P.W., Boneschans B. & Koeleman H.A. (1991), Rectal absorption of
phenytoin in rabbits from polyethylene glycol suppositories. Drug Development &
Industrial Pharmacy. 17(10), 1397-1404.
15. Samy E.M., Hassan M.A., Tous S.S. & Rhodes C.T. (2000), Improvement of
availability of allupurinol from pharmaceutical dosage forms I. Suppositories. Eur J
Pharm Biopharm. 49, 199-227.
16. Ross & Wilson., Anne Waugh & Allison Graws (eds), (2001), Anatomy &
Physiology in Health & Illness, 9th edition, Churchill Livingstone, Edinburg,.
17. Briemer D.D. & Boer A.G. (1985), Rate controlled rectal drug delivery in` man. J
Control Release. 2, 39-46.
18. Joseph T. (2002), Rectal & vaginal drug delivery system, Aultom ME (Eds).
Science of Dosage Form Design, 2nd edition, Churchill Livingstone, Edinburg;: 534-43
19. Gray’s Anatomy, (1991), 36th Edition edited by William PL & Warwick K.
Churchill Livingstone; 356-62.
20. http:// www.nation master com/ index php.
21. Onyeji C.O., Adebayo A.S.& Babalota C.P. (1999), Effects of absorption
enhancers in chloroquine suppository formulations: I In vitro release characteristics.
Eur J Pharm Sci. 9(2), 131-136.
22. Larry J.C. & Herbert A.L. Suppositories. In: Lachman L, Lieberman HA & Kanig
JC eds., (1991). Theory & Practice of Industrial Pharmacy, 3 rd edition, Varghese
Publishing House; Bombay:; 564-588
23. British Pharmcopoeia. (2002), Department of Health, Social Services & Public
Safety, London,
24. British Pharmcopoeia, (2002), Department of Health, Social Services & Public
Safety, London.
25. British Pharmcopoeia. (2002), Department of Health, Social Services & Public
Safety, London,
26. Wade A. & Weller P.J. (1994) H&book of Pharmaceutical Excipients, 2 nd Edition,
Ed Pharmaceutical Press. 517, 355-361.
27. Indian Pharmacopoeia published by Controller of Publications, New Delhi, Vol. I:
234.
28. British Pharmcopoeia, (2002), Department of Health, Social Services & Public
Safety, London, Vol.
29. Indian Pharmacopoeia published by Controller of Publications, New Delhi, Vol. I:
1996, 234.
30. Indian Pharmacopoeia Published by Controller of Publications, New Delhi, Vol. II:
1996, 235
31. Wade A. & Weller P.J. (1994) H&book of Pharmaceutical Excipients, 2 nd Edition,
Ed Pharmaceutical Press. 517, 355-361.
32. Indian Pharmacopoeia Published by Controller of Publications, New Delhi, Vol. II:
(1996), 685.
33. Lawrence H.B (Ed.). (1995), Suppositories, Remington: Science & Practice of
Pharmacy, 19th edition, Mack Publishing House, New York, 1591-1595.
34. Gold M. Nepuri M. & Lawrence H. Pharmaceutical Dosage Form: Disperse
System. Lieberman Rieger & Banker (Eds), New York, Marcel Dekker Inc. 2, 447-96.
35. Siewart M., Dressman J., Brown C.K., & Shah V.P. (2003), FTP / AAPS
Guidelines to Dissolution/ In Vitro release study testing of novel/ special dosage forms.
AAPS Pharmaceutech, 4(1). Article 7 available from url: http:// www.AAPS
pharmascitech.com
36. Lawrence H.B. (Ed.). Remington, (1995), Science & Practice of Pharmacy, 19th
edition, Mack Publishing House; New York: 1577.
37. Sweetman S.C. & Martindale. (2005), Complete Drug Reference. 34th ed.
Pharmaceutical Press. London (UK),11& 865.
38. Akala E.O., Adedoyn A. & Ogunbona F.A.(1991). Suppository formulation of
amodiaquine in vitro release characteristics. Drug Develop Ind Pharm. 17(2), 303-307.
39. Allen L.V. (1997), Suppositories as drug delivery system Part-2. Journal of
Pharmaceutical Care in Pain & Symptom Control. 5(2), 17-26.
40. Asikoglu M., Ertan G. & Cosar G. (1995), release of isoconazole nitrate from
different suppository bases: In vitro dissolution, physicochemical & microbiological
studies. J Pharm Pharmacol. 47(9), 713-6.
41. Axel S. & Christel C.M.G. (2000). Controlled release of solid-reversed –micellar-
solution (SRMS) suppositories. Int J Pharm. 196(2). 193-196
42. Basavaraj B.V., Sindhu A., Devaswaran R., Bharat S. & Madhavan V. (2007),
Mucoadhesive effect of carbopol on drug release rate from double phased
suppositories. Asian J Pharm. 1(1), 93-95.
43. Brummer J.M., Schoenmakers E.A.J.M., Kumerink G.J., Heidendal G.A.K., S&er
D.G.M. & Stockbrugger R.W. (1997), effect of single rectal dose of cisapride on
delayed gastric emptying. Aliment Pharmacol Ther. 11(4), 781-785.
44. Cyprian O.O., Amusa S.A & Chinedum P.B. (1999). Effects of absorption
enchancers in choloroquine suppository formulation:I: In vitro release characteristics.
Eur J Pharm Sci. 9(2). 131-136
45. Dash A.K. & Cudworth G.C. (2001), Evaluation of acetic acid ester of
monoglyceride as suppository base with unique properties. AAPS Pharmascitech, 2(3),
Article 13. Available from url: http:// www.AAPS pharmascitech.com.
46. Assasy E.l., Foda A.H., Badawi S.S. & Rahim R.T. (1995), Release
characteristics & bioavailability of pirprofen from suppository bases. Egyptian J Pharm
Sci. 36(1-6), 15-25.
47. Elbary A.A., Nabarawi M.A. & Mohamed M.I. (1998). Effect of chemical
structure on release of certain propionic acid derivatives from their dosage forms. Drug
Develop Ind Pharm.24(5), 439-451.
48. Taha E.I., Zaghoul A.A., Samy A.M., Saidan S., Kassem A.A. & Khan M.A.
(2004), Bioavailability assessment of salbutamol sulfate in human volunteers.
Int.J.Pharm. 279, 3-7.
49. Eva K., Konomi U., Peter F., Gerda S. & Gyorgy D. (2013). Novel sample
preparation method for surfactant containing suppositories: Effect of Miccelle formation
on drug recovery. J Pharm & Biomed Ana.(83), 149-156
50. Faruk A., Ashraful I.S., Qadir M.A. & Saleem R.M.D.(2004), Soluble drug
theophylline sodium glycinate from different suppository bases, Dhaka
Univ.J.Pharm.Sci. 3, 1-2.
51. Fontan J.E., Arnaud P. & Chaumeil J.C. (1991).Enhancing properties of
surfactant on release of carbamazepine form suppositories. Int J Pharm73(1). 17-21
52. Ghorab D., Refai H. & Tag R. (2011), Preparation & Evaluation of Fenotrol
hydrobroomide Sippositories. Drug Discov Ther. 5(6), 311-318
53. Han G.C., Mi-Kyung L., Moon-Hee K. & Chong-Kook Kim.(1999). Effect of
additivies on physicochemical properties of liquid suppository bases. Int J Pharm.190.
13-19
54. Hanaee J., Javadzadeh Y, Taftachi S., Farid D. & Nokhodchi A. (2004). Role of
various surfactant on release of salbutamol from suppositories. IL Farmaco. 59(11).
903-906.
55. Hender T., Hender J., Gellin F., Haung M.L., V&e P.S. & Woestenborghs R. et al,
(1990), Comparative bioavailability of cisapride suppository & tablet formulation in
healthy volunteers. Eur J Clin Pharmacol. 38(6), 629-631.
56. Hideo S., Mkiko F., Naoya K., Masua K. & Yoshiteru W. (2009). Novel
chronotherapeutic rectal aminophylline system for therapy of asthma. 379. 119-124
57. Hudson K.C., Asbill C.S. & Webster A.A. (2007) Isoniazid Release from
suppositories compounded with selected bases. Veternary Compounding. 15.
58. Iwata M., Takayama K., Takahashi Y., Obtata Y. & Shirotaka S. (1998),
Release of diclofenac sodium from suppositories consisting of witepsols as base.
Japanese J Hosp Pharm. 24(4), 3587-62.
59. Jawahar N., Jayaprakash S., Maria G.R.N.S., Nagarajan M., Dhachina M.D. &
Jibie S et al. (2005), Design& evaluation of sustained release suppositories of
nimesulide. Indian J Pharm Sci. 67(5), 558-561.
60. Kamlinder K.S., Deshp&e S.G. & Baichwal M.R., (1994),Studies on suppository
bases: Design & Evaluation of Sodium CMC & Agar bases. Indian Drugs. 31,
149-54.
61. Kirsti G. & Christina G. (1994). Influence of amount of hard fat in suppositories in
in vitro release rate & bioavailability of paracetamol II.A comparison between three
composition& rectal solution. Int J Pharm. 104(3). 215-226.
62. Khamaruzzaman M.A., Ashraful S.M., Jakir A.C. & Selim R.M.D. (2005), Effect of
Viscosity Imparting Agents on In-Vitro Drug Release from PEG Based Suppositories,
Dhaka.Univ.J.Pharm. 4(1), 77-80
63. Kim J.Y. & Ku Y.S. (2000). Enhanced absorption of indomethacin after oral or
rectal administration of self-emulsifying system containing indomethacin to rats. Int J
Pharm.194(1), 81-89.
64. Ozguney L., Ozcan L., Ertan G. & Guneri T. (2007), Preparation & evaluation of
sustained Release Suppositories of ketoprofen & Eudragit RL 100 by using Factorial
design. Pharm Dev Tech. 12, 97-107.
65. Lintz W., Barth H., Osteloh G., Schmidt. & Bothelt E. (1998). Pharmacokinetics
of tramadol & bioavailability of enteral tramadol formulation. 3rd Communication:
Suppositories. Arzneimittel forschung.48(9), 889-899.
66. Malladi S.P., Satyanarayana N.V., Prakash V.D. & Krishna D.R. (1992), Studies
on stability of fast & slow release compressed propranolol HCl suppositories. Indian. J
Pharm Sci. 54(6), 222-226.
67. Maitani Y., Takayama K., Iwata M., Komiya S., Nakamura K., Kiuchi M., &oh N. &
Hirahara F. (2001), Release property of progesterone from mixed-base suppository
consisting of witepsol W-35 & Witepsol E-85. Drug Dev Ind Pharm.27(10), 1039-1045.
68. Margarti M., Victoria., Caballero. & David J. (2003). Thermal & Rheological study
of lipophilic ethosuximide suppositories. Eur J Pharm Sci. 19(2-3). 123-128
69. Medina J.R., Padilla A.R.,Hurtado M., Cortes A.R. & Dominguez R.A.M. (2014),
In Vitro release of ketoprofen suppositories usinf USP basket & flow through cell
dissolution methods. Pak J Pharm Sci. 27(3), 453-458
70. Mohammed R.A., Abass H.A., Attia M.A .& Heikal O.A. (2013), Formulation&
evaluation of metoclopramide solid lipid nanoparticles for rectal suppository. J Pharm
Pharmacol. 65(11), 1607-21
71. Nair L. & Bhargava H.N. (1999), Comparison of in vitro dissolution & permeation
of fluconazole from different suppository bases. Drug Develop Ind Pharm. 25(5), 691-
4.
72. Nilufer T. & Ermid D. (1997). Sustained Release characteristrics &
pharmacokinetic parameters of ketoprofen suppositories using chitosan. Int J Pharm.
147. 71-77
73. Nishimura K., Hidaka R., Hirayama F., Arima H. & Uekama K. (2006).
Improvement of Dispersion & release properties of Nifedipine in suppositories by
complexation with 2-hyroxypropyl-β-cyclodextrin. J.Incl.Phen & Macrocyclic Chem.
56(1-2), 85-88.
74. P&it J.K., Choudhary P.K. & Mishra B. (1990). In vitro evaluation of pentazocine
suppositories. Eastern Pharmacist. 1, 171-173.
75. Pastzor E., Csoka G., Klebovich I. & Antal I. (2007). Formulation study of
Metolose based in situ gelling suppositories. Eur J Pharm Sci. (325). 522-S50
76. Ramarao P., Vijay Kumar D. & Diwan P.V. (1998). Comparative
pharmacokinetic evaluation of compressed rectal suppositories of diltiazem
hydrochlorid. Ind J Pharmacol. 30(3), 191-194.
77. Realdon N. & Ragazzi E. (2001), Effect of drug solubility on in vitro availability
rate from suppositories with polyethylene glycol excipients. Pharmazie. 56(2), 163-167.
78. Regdon G., Schirm S. & Regdon G. (1995). Formulation &in vitro study of
antimalarial rectal suppositories. Pharmazie. 50, 439-440.
79. Reiko Y., Hiraku O. & Yoshiharu M. (1999). Preparation & evaluation of double-
phased mucoadhesive suppositories of lidocaine utilizing carbopol & white beeswax. J
cont Rel. 61(1-2), 1-8
80. Rishiraj C., Harsha B., Patel., Rajan D.S., Jayanthi C. & Suresh B. (1999),
Formulation &in vitro characterization of chloroquine phosphate suppositories. Eastern
Pharmacist. 4, 117-118.
81. Ryu J.M., Chug S.J., Lee M.H., Kim C.K. & Chang K.S. (1999), Increased
bioavailability of propranolol in rats by retaining thermally gelling liquid suppositories.
J Control Release.59 (2), 163-172.
82. Maity S. & B&yopadhay .K. (2008), Development & evaluation of matrix & two
layered sustained release suppositories of theophylline. Boll Chim Farm. 140(6), 462-
466.
83. Sastri M.S., Satyanarayana M.V., Krishna D.R. & Diwan P.V. (1993),In vitro&in
vivo studies on slow release propranolol hydrochloride suppositories. Pharmacokinetic
& pharmacodynamic evaluation. Arzneimittel-Forchung. 43(3), 320-3.
84. Schmitt M. & Guentert T.W. (1990). Influence of hydrophilicity of suppository
bases on rectal absorption of carprofen, lipophilic non-steroidal anti-inflammatory drug.
J Pharm Sci. 79(4), 359-363.
85. Schneeweis A. & Muller G.C.C. (2000), Controlled release of solid-reversed-
micellar-solution (SRMS) suppositories containg Metaclopramide HCl. Int J Pharm.
196(2), 193-196
86. Stanislaw J., Malgorzata S., Weronika Z., Halina G. & Magdalena K. (2001).
Evaluation of paracetamol suppositories by pharmacopoeial test-comments on
methodology. Eur J Pharm &Biopharm.52(2). 249-254.
87. Adegboye T.A. & Itiola O. (2008), Physical & Release Properties of
Metronidazole Suppositories.Trop J. Pharm Res.7(1), 887-896
88. Takatori T., Shimono N., Higaki K. & Kimura T. (2004). Evaluation of sustained
release suppositories prepared with fatty base including solid fats with high melting
point. Int J Pharm. 278(2), 275-82.
89. Taneja L.M., Singh J. & Jaiswal S.B. (1981), Bioavailability of insulin from insulin
suppositories to rabbits; Vol. XXIV No. 288: 117-20
90. Tatsumi A., Oda S., Nakamoto T., Muraoka R., Takahashi V. & Tanaka K et al.
(2008), Release control of prednisolone from suppository prepared using pulverized
tablet. Yakugaku Zassi. 128(4), 641-648.
91. Tina K., Alex&ra G., Chantal B, Boubkar B., Muriel M. & Stepane M et al.
(2013),Pharmaceutical development & optimization of azithromycin suppository for
paediatric use. Int J Pharm. 441, 218-226
92. Tokiko O., Masaki Y.,Kimito T., Shinobu T., Kazumichi I., Osamu S., Sueaki I.,
Kozo T. & Tsuneji N.(1995).Int J Pharm.124. 27-35
93. Uzunkaya G. & Bergladi N. (2003),In vitro drug liberation & kinetics of sustained
release indomethacin suppository. IL Farmaco. 58(7), 509-512.
94. Watanbe K., Yakous S., Takayama K., Machida Y., Isowa K. & Nagai T. (1993).
Investigation on rectal absorbtion of indomethacin from sustained-release hydrogel
suppositories prepared with water soluble dietary fibers, xanthan gum & locust bean
gum. Biol Phar Bull.16(4), 391-394.
95. Yong C.S., Yang C.H., Rhee J.D., Lee B.J., Kim D.C. amd Kim D.D et al. (2004),
Enhanced rectal bioavailability of ibuprofen in rats by poloxamer 188 & menthol.
Int J Pharm. 269(1), 169-76.
96. Yuan Y., Ying C., Zhang L., Zhu H.P., Guo Y.S. & Zhong B et al.
(2012),Thermosensitive & mucoadhesive in situ gel based on poloxamer as new carrier
for rectal administration of nimesulide. Int J Pharm. 430, 114-119
97. Zia H., Rasheed S.F., Quadri M., Needham T.E. & Squillante E. (1998). Ketrolac
Tromethamine & Ketoprofen Suppositories: Release profiles &Bioavailability of Cocoa
Butter Base Formula in Rabbits. Int J Pharm Compd. 2(5). 390-393
98. British pharmacopoeia, (2001), version 5.0; data © crown copyright 2001, Index
+ © system simulation ltd, stationary office ltd.
99. URL: http:// www. Intaspharma.com/hifenac.htm. accessed January 16, 2005.
100. Richard A. H., Pamela C. & Champe (2009),“ lippincotts illustrated reviews
Pharmacology” Wolter Kulwer India Pvt Ltd New Delhi. 211
101. Sweetman S.C. (2005) Matindale Complete Drug Reference 34 th edition
pharmaceutical press London UK . 865.
102. Carter S.J. (2008), Cooper & Gun’s Dispensing for Pharmaceutical Students.12 th
ed. CBS Publishers, New Delhi. 232-252.
103. Coben L.J. & Liberman H.A. In: Lachman L, Libermann HA & Kanig JL. (1989),
(e 3rd ed. Varghese Publishing House, Mumbai. 580.
104. Jawahar N., Jayaprakash S., Maria G. R.N.S., Nagarajan M. Dhachina M.D. &
Jibie S et al. (2005), Design & evaluation of sustained release suppositories of
nimesulide. Indian J Pharm Sci. 67(5), 558-61
105. Senthil K.K., Thiruganasambantham P., Viswanathan S. & Ramamurthy M.
(2002), Development & evaluation of &rographolide (from &rographis paniculata) rectal
suppositories. Indian Drugs.39(12), 648-50.
106. Basvaraj B.V. & Nanjudaswamy N.G. (2005), Formulation & evaluation of
paracetamol suppositories adapting various bases & adjuvant. Indian Drugs. 42(5),
305-308.
107. Higuchi T. (1963), Mechanism of sustained action medication. Theoretical
analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci. 51,
1145-1149.
Peppas N.A. (1985), Analysis of Fickian & non-Fickian drug release from polymers.
Pharm Acta Helv. 60, 110-11.